Projected Income Statement: Kering

Forecast Balance Sheet: Kering

Forecast Balance Sheet - Kering
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 4,670 2,306 8,504 10,500 8,039 9,016 8,509 7,922
Change - -50.62% 268.78% 23.47% -23.44% 12.15% -5.62% -6.9%
Announcement Date 17/02/22 15/02/23 08/02/24 11/02/25 10/02/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Kering

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 934 1,071 2,611 3,309 830 876.8 925.2 973.8
Change - 14.67% 143.79% 26.73% -74.92% 5.64% 5.52% 5.25%
Free Cash Flow (FCF) 1 3,942 3,208 1,983 1,400 2,300 1,741 1,656 1,908
Change - -18.61% -38.19% -29.4% 64.29% -24.29% -4.9% 15.24%
Announcement Date 17/02/22 15/02/23 08/02/24 11/02/25 10/02/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Kering

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 36.67% 35.65% 33.57% 27.14% 25.04% 25.85% 26.82% 28.36%
EBIT Margin (%) 28.43% 27.46% 24.26% 14.85% 11.11% 12.58% 14.74% 16.79%
EBT Margin (%) 25.64% 25.23% 21.63% 9.88% 3.09% 7.82% 11.46% 13.64%
Net margin (%) 18% 17.76% 15.25% 6.59% 0.49% 4.34% 7.03% 8.81%
FCF margin (%) 22.34% 15.76% 10.13% 8.14% 15.67% 11.96% 10.71% 11.6%
FCF / Net Income (%) 124.11% 88.77% 66.48% 123.57% 3,194.44% 275.96% 152.36% 131.67%

Profitability

        
ROA 10.75% 11.12% 7.92% 2.67% 1.26% 1.78% 2.72% 3.94%
ROE 25.24% 25.34% 19.37% 7.52% 3.59% 5% 7.63% 9.77%

Financial Health

        
Leverage (Debt/EBITDA) 0.72x 0.32x 1.29x 2.25x 2.19x 2.4x 2.05x 1.7x
Debt / Free cash flow 1.18x 0.72x 4.29x 7.5x 3.5x 5.18x 5.14x 4.15x

Capital Intensity

        
CAPEX / Current Assets (%) 5.29% 5.26% 13.34% 19.25% 5.66% 6.02% 5.99% 5.92%
CAPEX / EBITDA (%) 14.43% 14.76% 39.75% 70.9% 22.59% 23.3% 22.32% 20.87%
CAPEX / FCF (%) 23.7% 33.39% 131.67% 236.36% 36.09% 50.36% 55.87% 51.03%

Items per share

        
Cash flow per share 1 39.13 34.7 36.43 38.4 25.26 25.57 26.38 28.08
Change - -11.34% 5.01% 5.4% -34.23% 1.22% 3.2% 6.41%
Dividend per Share 1 12 14 14 6 3 3.412 4.93 6.444
Change - 16.67% 0% -57.14% -50% 13.74% 44.48% 30.72%
Book Value Per Share 1 107.6 114.5 124.1 121.6 119.9 121.8 128.3 136.4
Change - 6.47% 8.35% -2.04% -1.34% 1.58% 5.32% 6.31%
EPS 1 25.49 29.31 24.37 9.24 0.59 5.035 8.842 11.93
Change - 14.99% -16.85% -62.08% -93.61% 753.33% 75.62% 34.95%
Nbr of stocks (in thousands) 123,744 122,233 121,646 122,587 122,601 122,618 122,618 122,618
Announcement Date 17/02/22 15/02/23 08/02/24 11/02/25 10/02/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 43.1x 24.5x
PBR 1.78x 1.69x
EV / Sales 2.45x 2.27x
Yield 1.57% 2.27%

EPS & Dividend

EPS & Dividend - Kering


Y-o-Y evolution of P/E

Valuation ratios - P/E - Kering
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Kering
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Kering
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
216.95EUR
Average target price
264.24EUR
Spread / Average Target
+21.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Kering